4B. Biochemistry

Oppenheim JJ Zachariae CO Mukaida N Matsushima K . Properties of the novel proinflammatory supergene “intercrine” cytokine family. Annu Rev Immunol 1991;9:617–48.

DeMaria TF Murwin DM . Tumor necrosis factor in endotoxin-induced otitis media in the chinchilla. In: Mogi G Honjo I Ishii T Takasaka T , eds. Recent Advances in Otitis Media. Proceedings of the Second Extraordinary International Symposium on Recent Advances in Otitis Media. Amsterdam, the Netherlands: Kugler Publications, 1994:633–5.

Nell MJ Grote JJ . Endotoxin and tumor necrosis factor–alpha in middle ear effusions in relation to upper airway infection. Laryngoscope 1999;109:1815–9.

Lin J Haruta A Kawano H . Induction of mucin gene expression in middle ear of rats by tumor necrosis factor–alpha: Potential cause for mucoid otitis media. J Infect Dis 2000;182:882–7.

Kawano H Haruta A Tsuboi Y . Induction of mucous cell metaplasia by tumor necrosis factor alpha in rat middle ear: The pathological basis for mucin hyperproduction in mucoid otitis media. Ann Otol Rhinol Laryngol 2002;111:415–22.

Lee DH Park YS Jung TT Yeo SW Choi YC Jeon E . Effect of tumor necrosis factor–alpha on experimental otitis media with effusion. Laryngoscope 2001;111:728–33.

Jeon EJ Park YS Choi YC Yeo SW Jung TT . Effect of inhibitor of tumor necrosis factor–alpha on experimental otitis media with effusion. Ann Otol Rhinol Laryngol 2001;110:917–21.

Barzilai A Leibovitz E Laver JH . Dynamics of interleukin-1 production in middle ear fluid during acute otitis media treated with antibiotics. Infection 1999;27:173–6.

Watanabe T Hirano T Suzuki M Kurono Y Mogi G . Role of interleukin-1 beta in a murine model of otitis media with effusion. Ann Otol Rhinol Laryngol 2001;110:574–80.

Yetiser S Satar B Gumusgun A Unal F Ozkaptan Y . Tumor necrosis factor–alpha and interleukin-1 beta levels in recurrent and persistent otitis media with effusion. Otolaryngol Head Neck Surg 2002;126:417–22.

Narkio-Makela M Teppo AM Meri S . Complement C3 cleavage and cytokines interleukin-1 beta and tumor necrosis factor–alpha in otitis media with effusion. Laryngoscope 2000;110:1745–9.

Kuziel WA Greene WC . Interleukin-2. In: Thompson A , ed. The cytokine handbook. New York, NY: Academic Press, 1991:83–102.

Melhus Å Ryan AF . Expression of cytokine genes during pneumococcal and nontypeable Hemophilus influenzae acute otitis media in the rat. Infect Immun 2000;68:4024–31.

Kita H Himi T . Cytokine and chemokine induction using cell wall component and toxin derived from gram-positive bacteria in the rat middle ear. Acta Otolaryngol (Stockh) 1999;119:446–52.

Staren ED Essner R Economou JS . Overview of biological response modifiers. Semin Surg Oncol 1989;5:379–84.

Strober W James SP . The interleukins. Pediatr Res 1988;24:549–57.

Sonoda E Hitoshi Y Yamaguchi N . Differential regulation of IgA production by TGF-beta and IL-5: TGF-beta induces surface IgA-positive cells bearing IL-5 receptor, whereas IL-5 promotes their survival and maturation into IgA-secreting cells. Cell Immunol 1992;140:158–72.

Sobol SE Taha R Schloss MD . T(H)2 cytokine expression in atopic children with otitis media with effusion. J Allergy Clin Immunol 2002;110:125–30.

Heikkinen T Ghaffar F Okorodudu AO Chonmaitree T . Serum interleukin-6 in bacterial and nonbacterial acute otitis media. Pediatrics 1998;102:296–9.

Hirano T . Interleukin-6. In: Thompson A , ed. The cytokine handbook. 2nd ed. New York, NY: Academic Press, 1994:145–70.

Sato K Liebeler CL Quartey MK Le CT Giebink GS . Middle ear fluid cytokine and inflammatory cell kinetics in the chinchilla otitis media model. Infect Immun 1999;67:1943–6.

Barzilaia A Dekel B Dagan R Leibovitz E . Middle ear effusion IL-6 concentration in bacterial and non-bacterial acute otitis media. Acta Paediatr 2000;89:1068–71.

Schroder JM . The neutrophil-activating peptidel/interleukin 8, a novel neutrophil chemotactic cytokine. Arch Immunol Ther Exp (Warsz) 1992;40:23–31.

Pospiech L Jaworska M Kubacka M . Soluble L-selectin and interleukin-8 in otitis media with effusion. Auris Nasus Larynx 2000;27:213–7.

Leibovitz E Dagan R Laver JH . Interleukin 8 in middle ear fluid during acute otitis media: Correlation with aetiology and bacterial eradication. Arch Dis Child 2000;82:165–8.

Schousboe LP Rasmussen LM Ovesen T . RANTES in otitis media with effusion: Presence, role and correlation with cytokines and microbiology. APMIS 2001;109:441–6.

Jang CH Kim YH . Demonstration of RANTES and eosinophilic cataionic protein in otitis media with effusion with allergy. Int J Pediatr Otorhinolaryngol 2003;67:531–3.

Smirnova MG Birchall JP Pearson JP . In vitro study of IL-8 and goblet cells: Possible role of IL-8 in the aetiology of otitis media with effusion. Acta Otolaryngol (Stockh) 2002;122:146–52.

Skotnicka B Hassmann E . Cytokines in children with otitis media with effusion. Eur Arch Otorhinolaryngol 2000;257:323–6.

Dong W Li Z Zhou S . Superoxide dismutase and cytokines in otitis media with effusion [in Chinese]. Lin Chuang Er Bi Yan Hou Ke Za Zhi 2001;15:452–4.

Hebda PA Piltcher OB Swarts JD Alper CM Zeevi A Doyle WJ . Cytokine profiles in a rat model of otitis media with effusion caused by eustachian tube obstruction with and without Streptococcus pneumoniae infection. Laryngoscope 2002;112:1657–62.

Jang CH Kim YH . Characterization of cytokines present in pediatric otitis media with effusion: Comparison of allergy positive and negative. Int J Pediatr Otorhinolaryngol 2002;66:37–40.

Downs BW Butehorn HF III Prazma J Rose AS Stamat JC Pillsbury HC III . Action of histamine on eustachian tube function. Otolaryngol Head Neck Surg 2001;124:414–20.

Ebert CS Jr. Pollock HW Dubin MG . Effect of intranasal histamine challenge on eustachian tube function. Int J Pediatr Otorhinolaryngol 2002;63:189–98.

Jung HJ Kim MW Lee JH . Expression of vascular endothelial growth factor in otitis media. Acta Otolaryngol (Stockh) 1999;119:801–8.

Rhee CK Jeong PS Kim YH Chung PS Jung TTK . Effect of platelet activating factor and its antagonist on the mucociliary clearance of the eustachian tube in guinea pigs. Ann Otol Rhinol Laryngol 1999;108:453–8.

Tjoelker LW Stafforini DM . Platelet-activating factor acetylhydrolases in health and disease. Biochim Biophys Acta 2000;1488:102–23.

Lin J Vambutas A Haruta A Paparella MM Giebink GS Kim Y . Pneumococcus activation of the 5-lipoxygenase pathway and production of glycoproteins in the middle ear of rats. J Infect Dis 1999;179:1145–51.

Tada N Furukawa M Ogura M . Experimental otitis media with effusion induced by leukotriene D4. Auris Nasus Larynx 2002;29:127–32.

Moncada S . The biology of nitric oxide. Funct Neurol 1997;12:134–40.

Takoudes TG Haddad J Jr. . Evidence of oxygen free radical damage in human otitis media. Otolaryngol Head Neck Surg 1999;120:638–42.

John EO Russell PT Nam BH Jinn TH Jung TT . Concentration of nitric oxide metabolites in middle ear effusion. Int J Pediatr Otorhinolaryngol 2001;60:55–8.

John EO O-Lee TJ Park SK Moorhead MT Jung TTK . Correlation between nitric oxide metabolites and mucin. In: Lim DJ Bluestone CD Casselbrant ML , eds. Abstracts of the Eighth International Symposium on Recent Advances in Otitis Media, Ft Lauderdale, Fla, 2003:71.

O-Lee TJ Park SK John EO Moorhead MT Jung TTK . Effect of nitric oxide on mucin production in experimental otitis media. In: Lim DJ Bluestone CD Casselbrant ML , eds. Abstracts of the Eighth International Symposium on Recent Advances in Otitis Media, Ft Lauderdale, Fla, 2003:72.

Morineau O Lecain E Portier F Tedguy A Tran Ba Huy P Herman P . Production of nitric oxide by the middle ear epithelium and subsequent inhibition of sodium transport. Acta Otolaryngol (Stockh) 2001;121:371–7.

Ondrey FG Juhn SK Adams GL . Early-response cytokine expression in adult middle ear effusions. Otolaryngol Head Neck Surg 1998;119:342–5.

Albino AP Kimmelman CP Parisier SC . Cholesteatoma: A molecular and cellular puzzle. Am J Otol 1998;19:7–19.

Ottaviani F Neglia CB Berti E . Cytokines and adhesion molecules in middle ear cholesteatoma. A role in epithelial growth?. Acta Otolaryngol (Stockh) 1999;119:462–7.

Albino AP Reed JA Bogdany JA Sassoon J Parisier SC . Increased numbers of mast cells in human middle ear cholesteatomas: Implications for treatment. Am J Otol 1998;19:266–72.

Akimoto R Pawankar R Yagi T Baba S . Acquired and congenital cholesteatoma: Determination of tumor necrosis factor–alpha, intercellular adhesion molecule-1, interleukin-1-alpha, and lymphocyte functional antigen-1 in the inflammatory process. ORL J Otorhinolaryngol Relat Spec 2000;62:257–65.

Chung JW Yoon TH . Different production of interleukin-1 alpha, interleukin-1 beta and interleukin-8 from cholesteatomatous and normal epithelium. Acta Otolaryngol (Stockh) 1998;118:386–91.

Schonermark M Mester B Kempf HG Blaser J Tschesche H Lenarz T . Expression of matrix-metalloproteinases and their inhibitors in human cholesteatomas. Acta Otolaryngol (Stockh) 1996;116:451–6.

Schonermark MP Issing PR Erbrich BK Lenarz T . Expression pattern of the plasminogen activator-plasmin system in human cholesteatoma. Ann Otol Rhinol Laryngol 1999;108:245–52.